NYSE: JOBY

Joby Aviation, Inc.

CIK 0001819848 · SIC 3721 · Aircraft

Small by revenue · Large by assets Revenue $53M Assets $2.8B as of Sep 13, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.

8-K Filed Sep 11, 2026 · Period ending Sep 10, 2026

Summary not yet generated.

8-K Filed Sep 9, 2026 · Period ending Sep 2, 2026

Joby Aviation appoints Sergey Novikov as Principal Accounting Officer

2 material changes detected. Sign up free to read the summary.

Partner

Trade JOBY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B5 Filed Aug 11, 2026

Joby Aviation launches up to $750M at-the-market offering at $8.81/share reference price

5 material changes detected. Sign up free to read the summary.

8-K Filed Aug 11, 2026 · Period ending Aug 8, 2026

Joby Aviation to acquire defense tech firm Resonant Sciences for ~$500M cash and stock

5 material changes detected. Sign up free to read the summary.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026

Joby Q2 2026: revenue +257493% to $38.6M; net loss narrows 24%

5 material changes detected. Sign up free to read the summary.

8-K Filed Aug 5, 2026 · Period ending Aug 5, 2026

Joby raises 2026 revenue guidance to $115-125M, expects first eIPP flights in September

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 28, 2026 · Period ending Jul 28, 2026

Joby Aviation warns 14.2M warrants expire Aug 10; NYSE halts trading Aug 7

3 material changes detected. Sign up free to read the summary.

8-K Filed Jun 30, 2026 · Period ending Jun 29, 2026

Joby and Toyota form 49/51 manufacturing JV for S4 eVTOL aircraft with future funding tied to $250M tranche

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 4, 2026 · Period ending Jun 2, 2026

Joby Aviation stockholders re-elect directors, ratify auditor at 2026 Annual Meeting

3 material changes detected. Sign up free to read the summary.

10-Q Filed May 6, 2026 · Period ending Mar 31, 2026

JOBY: revenue $24.2M, net income -$110.0M. Joby reports first revenue from Blade acquisition, faces Archer litigation threatening imports

5 material changes detected. Sign up free to read the summary.

8-K Filed May 5, 2026 · Period ending May 5, 2026

Joby Aviation reports Q1 2026 financial results

2 material changes detected. Sign up free to read the summary.

8-K Filed Apr 22, 2026 · Period ending Apr 20, 2026

Joby Aviation's Aircraft OEM President Didier Papadapoulos to resign July 3, 2026

2 material changes detected. Sign up free to read the summary.

8-K Filed Mar 11, 2026 · Period ending Mar 6, 2026

Joby Aviation acquires 728,000 sq ft Ohio facility for $61.5M, financed with $30.8M loan

4 material changes detected. Sign up free to read the summary.

8-K Filed Mar 6, 2026 · Period ending Mar 2, 2026 Red flag

Joby Aviation dismisses Deloitte, appoints PwC as auditor with no reported disputes

5 material changes detected. Sign up free to read the summary.

10-Q Filed Aug 7, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 8, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(In thousands, except share and per share data)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue 38,639 15 62,885 15
Operating expenses:
Cost of Revenue 28,298 10 47,101 10
Research and development 194,662 136,387 372,132 270,674
Selling, general and administrative 76,562 31,482 138,115 60,479
Total operating expenses 299,522 167,879 557,348 331,163
Loss from operations (260,883) (167,864) (494,463) (331,148)
Interest and other income, net 18,929 9,849 36,713 19,747
Loss on common stock issuance in private placement (40,258) (40,258)
Gain (loss) from change in fair value of warrants, earnout shares and contingent consideration, net (3,347) (126,295) 102,667 (55,275)
Total other income (loss), net 15,582 (156,704) 139,380 (75,786)
Loss before income taxes (245,301) (324,568) (355,083) (406,934)
Income tax expense 142 106 310 146
Net loss (245,443) (324,674) (355,393) (407,080)
Net loss per share, basic and diluted (0.25) (0.41) (0.37) (0.52)
Weighted-average common shares outstanding, basic and diluted 969,905,441 796,798,437 956,777,375 781,936,215

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands, except share and per share amounts)

Description June 30, 2026 December 31, 2025
Assets
Current assets:
Cash and cash equivalents 629,861 240,810
Short-term investments 1,633,965 1,167,106
Total cash, cash equivalents and short-term investments 2,263,826 1,407,916
Restricted cash 1,304 220
Accounts and other receivables 12,449 7,139
Prepaid expenses and other current assets 38,679 30,479
Total current assets 2,316,258 1,445,754
Property and equipment, net 229,828 146,571
Operating lease right-of-use assets 30,920 31,837
Restricted cash 4,903 693
Intangible assets 18,155 18,859
Goodwill 89,390 89,422
Other non-current assets 62,723 61,933
Total assets 2,752,177 1,795,069
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable 8,273 3,604
Operating lease liabilities, current portion 9,027 8,404
Accrued expenses and other current liabilities 111,558 48,018
Total current liabilities 128,858 60,026
Operating lease liabilities, net of current portion 24,531 26,167
Long-term debt 701,874
Warrant liability 21,505 104,878
Earnout shares liability 95,565 156,692
Other non-current liabilities 13,121 37,593
Total liabilities 985,454 385,356
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock: $0.0001 par value 100,000,000 shares authorized. No shares issued and outstanding.
Common stock: $0.0001 par value 2,800,000,000 shares authorized; 986,521,249 and 915,076,698 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. 99 91
Additional paid-in capital 4,913,728 4,193,684
Accumulated deficit (3,140,972) (2,785,579)
Accumulated other comprehensive income (loss) (6,132) 1,517
Total stockholders’ equity 1,766,723 1,409,713
Total liabilities and stockholders’ equity 2,752,177 1,795,069

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities
Net loss (355,393) (407,080)
Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization expense 22,853 18,885
Stock-based compensation expense 96,016 53,577
(Gain)/Loss from change in the fair value of warrants, earnout shares and contingent consideration, net (102,667) 55,276
Non-cash interest expense, and amortization of debt discount and issuance costs 3,614
Loss on common stock issuance in private placement 40,258
Net accretion and amortization of investments in marketable debt securities (1,937) (5,132)
Changes in operating assets and liabilities
Accounts and other receivables and prepaid expenses and other current assets (8,972) 13,343
Other non-current assets (333) 173
Accounts payable and accrued expenses and other current liabilities 58,113 12,053
Non-current liabilities (28,876) 1,114
Net cash used in operating activities (317,582) (217,533)
Cash flows from investing activities
Purchases of marketable securities (814,141) (285,428)
Proceeds from sales and maturities of marketable securities 341,339 368,673
Purchases of property and equipment and other long-lived assets (106,559) (27,089)
Acquisitions, net of cash 39
Net cash provided by (used in) investing activities (579,322) 56,156
Cash flows from financing activities
Underwritten public offering gross proceeds 600,000
Underwritten public offering commission and offering expenses (23,664)
Gross proceeds from issuance of convertible notes 690,000
Convertible notes underwriting discounts and commissions and issuance costs (20,311)
Proceeds from mortgage loan 30,750
Payment for capped call transactions (63,273)
Proceeds from issuance of common stock in private placement, net 249,905
At-the-market public offering gross proceeds 44,529
At-the-market public offering commission and offering expenses (1,567)
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 8,191 5,022
Proceeds from the exercise of stock options and warrants 70,690 964
Repayments of obligations under finance lease and tenant improvement loan (1,134) (859)
Net cash provided by financing activities 1,291,249 297,994
Net change in cash, cash equivalents and restricted cash 394,345 136,617
Cash, cash equivalents and restricted cash, at the beginning of the period 241,723 200,389
Cash, cash equivalents and restricted cash, at the end of the period 636,068 337,006
Reconciliation of cash, cash equivalents and restricted cash in balance sheets
Cash and cash equivalents 629,861 336,313
Restricted cash 6,207 693
Cash, cash equivalents and restricted cash in balance sheets 636,068 337,006
Non-cash investing and financing activities
Unpaid property and equipment purchases 2,014 5,460
Property and equipment purchased through finance leases 3,602 3,665
Right-of-use assets acquired through operating leases 3,496 1,990

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share and per share data); (In thousands, except share and per share amounts); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing